Welcome back to MedfyleToday - your daily highlights brought to you directly from the American Diabetes Association's 83rd Scientific Sessions®.

Today, we are pleased to inform you that we had the opportunity to interview Ralph DeFronzo, MD, to gather his insights on initial combination therapy for type 2 diabetes. He delves deep into the potential advantages of initial combination therapy compared to the traditional stepwise approach, as well as the most effective drug combinations to utilize. Additionally, you can tune in to hear Bijan Najafi, PhD, discuss exciting new advancements in the utilization of artificial intelligence for the management of diabetic foot disease.

In today's overview video, Vivian Fonseca, MD, highlights the most captivating presentations from Day 2 of the 83rd Scientific Sessions. There has been significant focus on continuous glucose monitoring, as well as new findings regarding once-weekly icodec versus the current standard of care, once-daily insulin glargine U100.